icd10coded.com
  • ICD-10 CM
    • ICD-10 CM Diagnosis Codes
    • Convert ICD-9 to ICD-10
    • Index of Diseases and Injuries
    • Index of External Cause of Injuries
    • Table of Neoplasms
    • Table of Drugs & Chemicals
    • POA Reporting Guidelines
    • POA Codes
    • Diagnosis Related Groups - MS-DRG
  • ICD-10 PCS
    • ICD-10 PCS Procedure Codes
    • ICD-10 PCS Index
    • ICD-10 PCS Definitions
    • Device Aggregation Table
    • Diagnosis Related Groups - MS-DRG
  • Coding Rules
    • Perinatal/Newborn diagnoses
    • Pediatric diagnoses
    • Maternity diagnoses
    • Adult diagnoses
    • Diagnoses for females only
    • Diagnoses for males only
    • Procedures for females only
    • Procedures for males only
    • Unacceptable principal diagnosis
    • Questionable admission codes
    • Manifestation code as principal diagnosis
  • Clinical Concept
    • Allergy
    • Cardiology
    • Endocrinology
    • Family Practice
    • Internal Medicine
    • OB/GYN
    • Orthopedics
    • Pediatrics
    • Physical Therapy
  • Search
  1. Home
  2. ICD-10 CM
  3. C96.29
  4. Feedback

ICD-10 Code C96.29
Other malignant mast cell neoplasm

C96.29 is a specific diagnostic code in the ICD-10-CM classification system used for other malignant mast cell neoplasms, a group of rare hematopoietic malignancies characterized by the uncontrolled, abnormal proliferation and accumulation of cancerous mast cells in various tissues and body systems. This code is typically assigned when a patient presents with a pathologically confirmed malignant mast cell tumor or advanced systemic clonal mast cell disease that does not specifically meet the clinical criteria for classic aggressive systemic mastocytosis or mast cell sarcoma, such as certain rare forms of mast cell leukemia or specified aggressive variant mast cell tumors. Patients affected by these malignancies often experience severe organ damage due to tissue infiltration alongside systemic symptoms driven by heavy mast cell mediator release, including recurrent flushing, severe anaphylactoid reactions, peptic ulcer disease, hepatosplenomegaly, cytopenias, and osteolytic bone lesions. Related diseases and conditions that fall within or closely connect to this disease spectrum include systemic mastocytosis, mast cell leukemia, aggressive systemic mastocytosis, mast cell sarcoma, cutaneous mastocytosis, systemic mastocytosis with an associated hematologic neoplasm, and advanced myeloproliferative disorders.


C96.29 is a valid billable ICD-10 diagnosis code for Other malignant mast cell neoplasm. It is found in the 2027 version of the ICD-10 CM Index and can be used in all HIPAA-covered transactions from Oct 01, 2026 - Sep 30, 2027.


See also, ICD-10 Table of Neoplasms.

MS-DRG - Medicare Severity-Diagnosis Related Group
  • MDC 17 Myeloproliferative Diseases & Disorders, Poorly Differentiated Neoplasms
    Lymphoma and Leukemia with Major Procedure
    • DRG 820 - LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURE WITH MCC
    • DRG 821 - LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURE WITH CC
    • DRG 822 - LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURE WITHOUT CC/MCC
  • MDC 17 Myeloproliferative Diseases & Disorders, Poorly Differentiated Neoplasms
    Lymphoma and Non-Acute Leukemia with Other Procedure
    • DRG 823 - LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURE WITH MCC
    • DRG 824 - LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURE WITH CC
    • DRG 825 - LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURE WITHOUT CC/MCC
  • MDC 17 Myeloproliferative Diseases & Disorders, Poorly Differentiated Neoplasms
    Lymphoma and Non-Acute Leukemia
    • DRG 840 - LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MCC
    • DRG 841 - LYMPHOMA AND NON-ACUTE LEUKEMIA WITH CC
    • DRG 842 - LYMPHOMA AND NON-ACUTE LEUKEMIA WITHOUT CC/MCC

Coding structure:

ICD-10 code C96.29 is based on the following Tabular structure:

Chapter 2: Neoplasms
  • Section C81-C96: Malignant neoplasms of lymphoid, hematopoietic and related tissue
    • Category C96: Other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue

↑ Parent code:
C96.2 for Malignant mast cell neoplasm

C96.29__
Category
 
Etiology, Anatomic Site,
Severity, Other Vital Details
Extension

Should you use C96.29 or C9629 (with or without decimal point) when submitting claims?

DO NOT include the decimal point when electronically filing claims as it may be rejected. Some clearinghouses may remove it for you but to avoid having a rejected claim due to an invalid ICD-10 code, do not include the decimal point when submitting claims electronically.

Section C81-C96 — Malignant neoplasms of lymphoid, hematopoietic and related tissue

Excludes2

  • Kaposi's sarcoma of lymph nodes (C46.3)
  • secondary and unspecified neoplasm of lymph nodes (C77.-)
  • secondary neoplasm of bone marrow (C79.52)
  • secondary neoplasm of spleen (C78.89)
  1. C96 Other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue

    Excludes1

    • personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues (Z85.79)
    1. C96.0 Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis

      Inclusion term(s):

      • Histiocytosis X, multisystemic
      • Letterer-Siwe disease
    2. C96.2 Malignant mast cell neoplasm

      1. C96.20 Malignant mast cell neoplasm, unspecified

      2. C96.21 Aggressive systemic mastocytosis

      3. C96.22 Mast cell sarcoma

      4. C96.29 Other malignant mast cell neoplasm

    3. C96.4 Sarcoma of dendritic cells (accessory cells)

      Inclusion term(s):

      • Follicular dendritic cell sarcoma
      • Interdigitating dendritic cell sarcoma
      • Langerhans cell sarcoma
    4. C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis

      Inclusion term(s):

      • Hand-Schüller-Christian disease
      • Histiocytosis X, multifocal
    5. C96.6 Unifocal Langerhans-cell histiocytosis

      Inclusion term(s):

      • Eosinophilic granuloma
      • Histiocytosis X, unifocal
      • Histiocytosis X NOS
      • Langerhans-cell histiocytosis NOS
    6. C96.9 Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified

    7. C96.A Histiocytic sarcoma

      Inclusion term(s):

      • Malignant histiocytosis
    8. C96.Z Other specified malignant neoplasms of lymphoid, hematopoietic and related tissue

Abbreviations used here:

NEC Not elsewhere classifiable
This abbreviation in the Tabular List represents “other specified”. When a specific code is not available for a condition, the Tabular List includes an NEC entry under a code to identify the code as the “other specified” code.

NOS Not otherwise specified
This abbreviation is the equivalent of unspecified.

This note further define, or give examples of, the content of the code or category.

List of terms is included under some codes. These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of “other specified” codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.

Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10 CM has a coding convention that requires the underlying condition be sequenced first, if applicable, followed by the manifestation. Wherever such a combination exists, there is a “use additional code” note at the etiology code, and a “code first” note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.

A type 1 Excludes note is a pure excludes. It means 'NOT CODED HERE!' An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.

A type 2 Excludes note represents 'Not included here'. An Excludes2 note indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When an Excludes2 note appears under a code it is acceptable to use both the code and the excluded code together.

A “code also” note instructs that two codes may be required to fully describe a condition, but this note does not provide sequencing direction. The sequencing depends on the circumstances of the encounter.

Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10 CM has a coding convention that requires the underlying condition be sequenced first, if applicable, followed by the manifestation. Wherever such a combination exists, there is a “use additional code” note at the etiology code, and a “code first” note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.

Feedback

Finding the right ICD-10 code is not always easy. Submitting the wrong code can cause delays in processing claims and payments. Please let us know if there is anything we can do better to help make your job easier. We strive to be the best ICD-10 site possible.

Share this page

Was the information found on this page useful? Share this page with a friend or colleague. They may also find it useful. We can send an email to someone you designate with this information as well.

  • ICD-10 CM
  • ICD-10 PCS
  • FAQs
  • Sitemap
  • →
  • Terms of Use
  • Privacy Policy
  • Contact Us
Follow @icd10coded

ICD-10 data provided by CMS (Centers for Medicare & Medicaid Services). All content is provided “AS IS”. The latest version of ICD-10 is updated each year on October 1.

1.261103a — Privacy Settings